ELISA – News and Features

Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases.

A study conducted at the University of Helsinki, Finland set out to determine how 13 dog breeds performed in various cognitive tests. With a sample size of over 1,000 dogs, the researchers found several breed differences in traits such as social cognition, problem-solving ability and inhibitory control.

In this interview, CEO of Arrayjet Dr. Iain McWilliam discusses advancements in modern microarray technology and the benefits that these tools can provide for high-throughput screening.

Scientists have developed an electrochemical immunosensor that rapidly detects antibodies against SARS-CoV-2.

Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.

This article will highlight the properties of an attractive drug target, outline the approaches used to identify targets and discuss the key steps involved in target validation.

According to research, a new therapy currently undergoing clinical trials promotes a potent immune response by binding to fibroblasts, enabling it to overcome resistance to anti-HER2 therapy in tumors.

Researchers investigating why weighted blankets may ease insomnia have identified that using a weighted blanket boosts the levels of melatonin, the hormone that increases in response to darkness.

This article will highlight various analytical techniques employed in biopharmaceutical analysis and explore their use at different stages of the development pipeline.

A research team recently invented an accurate rapid-testing device that can quantify and display the antibody level as a length of a visual bar, like a mercury thermometer, in as few as 20 minutes.